View Author
influenza vaccination influenza vaccination vaccine study mortality revaccination trial population death epidemic response disease person virus infection individual influenza vaccine strain mortality risk influenza vaccines cohort pneumonia period community dwelling chapter subject effect patient adult protection health comorbidity outcome antibody effectiveness reduction status community criteria fluenza table study entry season seroprotection 65 years arch intern med result history efficacy vaccinated titre baseline dwelling netherland practice increase number hazard immunogenicity reference follow-up vaccination coverage group factor diabetes mellitus tract database entry parameter information ratio voordouw 2004. exposure vaccination history vaccination status health status benefit antibody response
4 Most Recent Publications
|
Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002
(Article)
Voordouw, A.C.G. Beyer, W.E.Ph. Smith, D.J. Sturkenboom, M.C.J.M. Stricker, B.H.Ch. |
2009-12-11
|
|
Mortality benefits of influenza vaccination in elderly people
(Article)
Sturkenboom, M.C.J.M. Dieleman, J.P. Stricker, B.H.Ch. Voordouw, A.C.G. |
2008-08-01
|
|
Influenza Vaccination in Community Dwelling Elderly Persons
(Doctoral Thesis)
Voordouw, A.C.G. |
2005-11-23
|
|
Annual revaccination against influenza and mortality risk in community-dwelling elderly persons.
(Article)
Voordouw, A.C.G. Sturkenboom, M.C.J.M. Dieleman, J.P. Stijnen, Th. Smith, D.J. Lei, J. van der Stricker, B.H.Ch. |
2004-11-03
|
